Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Kinetics of Torque Teno Virus-DNA Plasma Load Predict Rejection in Lung Transplant Recipients.

Frye BC, Bierbaum S, Falcone V, Köhler TC, Gasplmayr M, Hettich I, Dürk T, Idzko M, Zissel G, Hengel H, Müller-Quernheim J.

Transplantation. 2018 Sep 17. doi: 10.1097/TP.0000000000002436. [Epub ahead of print]

PMID:
30234787
2.

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis.

Goldmann T, Zissel G, Watz H, Drömann D, Reck M, Kugler C, Rabe KF, Marwitz S.

Respir Res. 2018 Jul 24;19(1):138. doi: 10.1186/s12931-018-0841-9.

3.

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U.

PLoS One. 2018 Jan 25;13(1):e0192058. doi: 10.1371/journal.pone.0192058. eCollection 2018.

4.

Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota.

Zimmermann A, Knecht H, Häsler R, Zissel G, Gaede KI, Hofmann S, Nebel A, Müller-Quernheim J, Schreiber S, Fischer A.

Eur Respir J. 2017 Dec 14;50(6). pii: 1600746. doi: 10.1183/13993003.00746-2016. Print 2017 Dec.

PMID:
29242257
5.

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U.

PLoS One. 2017 Sep 28;12(9):e0185350. doi: 10.1371/journal.pone.0185350. eCollection 2017. Erratum in: PLoS One. 2018 Jan 25;13(1):e0192058.

6.

P2Y6 Receptor Activation Promotes Inflammation and Tissue Remodeling in Pulmonary Fibrosis.

Müller T, Fay S, Vieira RP, Karmouty-Quintana H, Cicko S, Ayata CK, Zissel G, Goldmann T, Lungarella G, Ferrari D, Di Virgilio F, Robaye B, Boeynaems JM, Lazarowski ER, Blackburn MR, Idzko M.

Front Immunol. 2017 Aug 22;8:1028. doi: 10.3389/fimmu.2017.01028. eCollection 2017.

7.

Sarcoidosis: Drugs under Investigation.

Schupp JC, Frye BC, Zissel G, Müller-Quernheim J.

Semin Respir Crit Care Med. 2017 Aug;38(4):532-537. doi: 10.1055/s-0037-1603768. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750466
8.

The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease.

Müller T, Fay S, Vieira RP, Karmouty-Quintana H, Cicko S, Ayata K, Zissel G, Goldmann T, Lungarella G, Ferrari D, Di Virgilio F, Robaye B, Boeynaems JM, Blackburn MR, Idzko M.

Oncotarget. 2017 May 30;8(22):35962-35972. doi: 10.18632/oncotarget.16414.

9.

Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.

Plönes T, Fischer M, Höhne K, Sato H, Müller-Quernheim J, Zissel G.

Pathol Oncol Res. 2017 Oct;23(4):723-730. doi: 10.1007/s12253-016-0181-3. Epub 2017 Jan 4.

PMID:
28054314
10.

Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.

Schnerch J, Prasse A, Vlachakis D, Schuchardt KL, Pechkovsky DV, Goldmann T, Gaede KI, Müller-Quernheim J, Zissel G.

Am J Respir Cell Mol Biol. 2016 Nov;55(5):749-757.

PMID:
27390897
11.

Local Concentrations of CC-Chemokine-Ligand 18 Correlate with Tumor Size in Non-small Cell Lung Cancer and Are Elevated in Lymph Node-positive Disease.

Schmid S, Le UT, Haager B, Mayer O, Dietrich I, Elze M, Kemna LJ, Zissel G, Passlick B.

Anticancer Res. 2016 Sep;36(9):4667-71.

PMID:
27630310
12.

Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations.

Kishore A, Žižková V, Kocourková L, Petrkova J, Bouros E, Nunes H, Loštáková V, Müller-Quernheim J, Zissel G, Kolek V, Bouros D, Valeyre D, Petrek M.

Front Immunol. 2016 Jul 11;7:274. doi: 10.3389/fimmu.2016.00274. eCollection 2016.

13.

[New Pathogenetic Concepts and Early Pharmacological Studies in Sarcoidosis].

Schupp JC, Frye BC, Zissel G, Müller-Quernheim J.

Pneumologie. 2016 Apr;70(4):231-40. doi: 10.1055/s-0041-108311. Epub 2016 Mar 3. Review. German.

PMID:
26937647
14.

Specific antigen(s) in sarcoidosis: a link to autoimmunity?

Zissel G, Müller-Quernheim J.

Eur Respir J. 2016 Mar;47(3):707-9. doi: 10.1183/13993003.01791-2015. No abstract available.

15.

Cellular Players in the Immunopathogenesis of Sarcoidosis.

Zissel G, Müller-Quernheim J.

Clin Chest Med. 2015 Dec;36(4):549-60. doi: 10.1016/j.ccm.2015.08.016. Review.

PMID:
26593132
16.

Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.

Schmid S, Kübler M, Korcan Ayata C, Lazar Z, Haager B, Hoßfeld M, Meyer A, Cicko S, Elze M, Wiesemann S, Zissel G, Passlick B, Idzko M.

Lung Cancer. 2015 Dec;90(3):516-21. doi: 10.1016/j.lungcan.2015.10.005. Epub 2015 Oct 9.

PMID:
26505137
17.

Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.

Cicko S, Grimm M, Ayata K, Beckert J, Meyer A, Hossfeld M, Zissel G, Idzko M, Müller T.

Respir Res. 2015 Sep 15;16:105. doi: 10.1186/s12931-015-0264-9.

18.

Are bronchoalveolar lavages a good source for microbial profiling? Differences between throat and bronchoalveolar lavage microbiomes.

Zimmermann A, Zissel G, Müller-Quernheim J, Hofmann S, Schreiber S, Fischer A.

J Med Microbiol. 2015 Aug;64(8):948-951. doi: 10.1099/jmm.0.000112. No abstract available.

PMID:
26271248
19.

Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis.

Schupp JC, Binder H, Jäger B, Cillis G, Zissel G, Müller-Quernheim J, Prasse A.

PLoS One. 2015 Jan 15;10(1):e0116775. doi: 10.1371/journal.pone.0116775. eCollection 2015.

20.

The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease.

Hector A, Kröner C, Carevic M, Bakele M, Rieber N, Riethmüller J, Griese M, Zissel G, Hartl D.

Eur Respir J. 2014 Dec;44(6):1608-15. doi: 10.1183/09031936.00070014. Epub 2014 Aug 19.

21.

Cellular activation in the immune response of sarcoidosis.

Zissel G.

Semin Respir Crit Care Med. 2014 Jun;35(3):307-15. doi: 10.1055/s-0034-1376861. Epub 2014 Jul 9. Review.

PMID:
25007083
22.

mRNA and miRNA analyses in cytologically positive endobronchial ultrasound-guided transbronchial needle aspiration: implications for molecular staging in lung cancer patients.

Plönes T, Elze M, Kayser G, Pfeifer D, Burger M, Zissel G.

Cancer Cytopathol. 2014 Apr;122(4):292-8. doi: 10.1002/cncy.21398. Epub 2014 Feb 26.

23.

Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.

Stahl M, Schupp J, Jäger B, Schmid M, Zissel G, Müller-Quernheim J, Prasse A.

PLoS One. 2013 Nov 20;8(11):e81382. doi: 10.1371/journal.pone.0081382. eCollection 2013.

24.

[Genetic risk profile of sarcoidosis].

Fischer A, Zissel G, Nebel A, Müller-Quernheim J.

Internist (Berl). 2014 Feb;55(2):135-40. doi: 10.1007/s00108-013-3308-6. German.

PMID:
24217528
25.

CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential.

Ploenes T, Scholtes B, Krohn A, Burger M, Passlick B, Müller-Quernheim J, Zissel G.

PLoS One. 2013;8(1):e53068. doi: 10.1371/journal.pone.0053068. Epub 2013 Jan 18.

26.

Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis.

Hofmann S, Fischer A, Nothnagel M, Jacobs G, Schmid B, Wittig M, Franke A, Gaede KI, Schürmann M, Petrek M, Mrazek F, Pabst S, Grohé C, Grunewald J, Ronninger M, Eklund A, Rosenstiel P, Höhne K, Zissel G, Müller-Quernheim J, Schreiber S.

Eur Respir J. 2013 Apr;41(4):888-900. doi: 10.1183/09031936.00033812. Epub 2012 Aug 30.

27.

Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas.

Plönes T, Krohn A, Burger M, Veelken H, Passlick B, Müller-Quernheim J, Zissel G.

PLoS One. 2012;7(7):e41746. doi: 10.1371/journal.pone.0041746. Epub 2012 Jul 25.

28.

A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1.

Fischer A, Schmid B, Ellinghaus D, Nothnagel M, Gaede KI, Schürmann M, Lipinski S, Rosenstiel P, Zissel G, Höhne K, Petrek M, Kolek V, Pabst S, Grohé C, Grunewald J, Ronninger M, Eklund A, Padyukov L, Gieger C, Wichmann HE, Nebel A, Franke A, Müller-Quernheim J, Hofmann S, Schreiber S.

Am J Respir Crit Care Med. 2012 Nov 1;186(9):877-85. doi: 10.1164/rccm.201204-0708OC. Epub 2012 Jul 26.

PMID:
22837380
29.

Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type II.

Höhne K, Schliessmann SJ, Kirschbaum A, Plönes T, Müller-Quernheim J, Tenor H, Zissel G.

PLoS One. 2012;7(7):e38369. doi: 10.1371/journal.pone.0038369. Epub 2012 Jul 16.

30.

Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.

Kollert F, Christoph S, Probst C, Budweiser S, Bannert B, Binder M, Sehnert B, Voll RE, Warnatz K, Zissel G, Walker UA, Prasse A, Saalbach A.

Arthritis Care Res (Hoboken). 2013 Feb;65(2):281-7. doi: 10.1002/acr.21799.

31.

Pathogenesis of sarcoidosis.

Müller-Quernheim J, Prasse A, Zissel G.

Presse Med. 2012 Jun;41(6 Pt 2):e275-87. doi: 10.1016/j.lpm.2012.03.018. Epub 2012 May 15. Review.

PMID:
22595775
32.

CCL18 -- potential biomarker of fibroinflammatory activity in chronic periaortitis.

Kollert F, Binder M, Probst C, Uhl M, Zirlik A, Kayser G, Voll RE, Peter HH, Zissel G, Prasse A, Warnatz K.

J Rheumatol. 2012 Jul;39(7):1407-12. doi: 10.3899/jrheum.111143. Epub 2012 May 15.

PMID:
22589264
33.

Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro.

Müller-Quernheim UC, Potthast L, Müller-Quernheim J, Zissel G.

J Interferon Cytokine Res. 2012 Apr;32(4):169-77. doi: 10.1089/jir.2011.0020. Epub 2012 Jan 26.

34.

Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung.

Schultz H, Marwitz S, Baron-Lühr B, Zissel G, Kugler C, Rabe KF, Zabel P, Vollmer E, Gerdes J, Goldmann T.

Br J Cancer. 2011 Aug 23;105(5):673-81. doi: 10.1038/bjc.2011.281. Epub 2011 Aug 2.

35.

Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation.

Vieira RP, Müller T, Grimm M, von Gernler V, Vetter B, Dürk T, Cicko S, Ayata CK, Sorichter S, Robaye B, Zeiser R, Ferrari D, Kirschbaum A, Zissel G, Virchow JC, Boeynaems JM, Idzko M.

Am J Respir Crit Care Med. 2011 Jul 15;184(2):215-23. doi: 10.1164/rccm.201011-1762OC. Epub 2011 Apr 21.

PMID:
21512170
36.

Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction.

Pechkovsky DV, Prasse A, Kollert F, Engel KM, Dentler J, Luttmann W, Friedrich K, Müller-Quernheim J, Zissel G.

Clin Immunol. 2010 Oct;137(1):89-101. doi: 10.1016/j.clim.2010.06.017. Epub 2010 Jul 31.

PMID:
20674506
37.

Immunologic response of sarcoidosis.

Zissel G, Prasse A, Müller-Quernheim J.

Semin Respir Crit Care Med. 2010 Aug;31(4):390-403. doi: 10.1055/s-0030-1262208. Epub 2010 Jul 27. Review.

PMID:
20665389
38.

Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis.

Biller H, Ruprecht B, Gaede KI, Müller-Quernheim J, Zissel G.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):139-46.

PMID:
20560294
39.

Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema.

Cicko S, Lucattelli M, Müller T, Lommatzsch M, De Cunto G, Cardini S, Sundas W, Grimm M, Zeiser R, Dürk T, Zissel G, Boeynaems JM, Sorichter S, Ferrari D, Di Virgilio F, Virchow JC, Lungarella G, Idzko M.

J Immunol. 2010 Jul 1;185(1):688-97. doi: 10.4049/jimmunol.0904042. Epub 2010 Jun 2.

40.

P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema.

Lucattelli M, Cicko S, Müller T, Lommatzsch M, De Cunto G, Cardini S, Sundas W, Grimm M, Zeiser R, Dürk T, Zissel G, Sorichter S, Ferrari D, Di Virgilio F, Virchow JC, Lungarella G, Idzko M.

Am J Respir Cell Mol Biol. 2011 Mar;44(3):423-9. doi: 10.1165/rcmb.2010-0038OC. Epub 2010 May 27.

PMID:
20508069
41.

Local administration of uridine suppresses the cardinal features of asthmatic airway inflammation.

Müller T, Grimm M, de Vieira RP, Cicko S, Dürk T, Sorichter S, Zissel G, Idzko M.

Clin Exp Allergy. 2010 Oct;40(10):1552-60. doi: 10.1111/j.1365-2222.2010.03518.x.

PMID:
20455899
42.

Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.

Prasse A, Zissel G, Lützen N, Schupp J, Schmiedlin R, Gonzalez-Rey E, Rensing-Ehl A, Bacher G, Cavalli V, Bevec D, Delgado M, Müller-Quernheim J.

Am J Respir Crit Care Med. 2010 Aug 15;182(4):540-8. doi: 10.1164/rccm.200909-1451OC. Epub 2010 May 4.

PMID:
20442436
43.

Extracellular adenosine triphosphate and chronic obstructive pulmonary disease.

Lommatzsch M, Cicko S, Müller T, Lucattelli M, Bratke K, Stoll P, Grimm M, Dürk T, Zissel G, Ferrari D, Di Virgilio F, Sorichter S, Lungarella G, Virchow JC, Idzko M.

Am J Respir Crit Care Med. 2010 May 1;181(9):928-34. doi: 10.1164/rccm.200910-1506OC. Epub 2010 Jan 21.

PMID:
20093639
44.

Essential role of osteopontin in smoking-related interstitial lung diseases.

Prasse A, Stahl M, Schulz G, Kayser G, Wang L, Ask K, Yalcintepe J, Kirschbaum A, Bargagli E, Zissel G, Kolb M, Müller-Quernheim J, Weiss JM, Renkl AC.

Am J Pathol. 2009 May;174(5):1683-91. doi: 10.2353/ajpath.2009.080689. Epub 2009 Apr 9.

45.

CCL18 production is decreased in alveolar macrophages from cigarette smokers.

Kollert F, Probst C, Müller-Quernheim J, Zissel G, Prasse A.

Inflammation. 2009 Jun;32(3):163-8. doi: 10.1007/s10753-009-9115-5.

PMID:
19357939
46.

[Genetics of sarcoidosis: a key to understanding its pathogenesis].

Müller-Quernheim J, Schürmann M, Hofmann S, Gaede KI, Fischer A, Prasse A, Zissel G, Schreiber S.

Pneumologie. 2009 Mar;63(3):166-75. Review. German.

PMID:
19271290
47.

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.

Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, Olschewski M, Rottoli P, Müller-Quernheim J.

Am J Respir Crit Care Med. 2009 Apr 15;179(8):717-23. doi: 10.1164/rccm.200808-1201OC. Epub 2009 Jan 29.

PMID:
19179488
48.

The hidden macrophage.

Zissel G.

Respiration. 2009;77(2):129-31. doi: 10.1159/000170609. Epub 2008 Nov 4. No abstract available.

PMID:
18984942
49.

Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma.

Jungraithmayr W, Frings C, Zissel G, Prasse A, Passlick B, Stoelben E.

Respirology. 2008 Nov;13(7):1022-7. doi: 10.1111/j.1440-1843.2008.01391.x. Epub 2008 Aug 26.

PMID:
18764914
50.

Activation of human alveolar macrophages via P2 receptors: coupling to intracellular Ca2+ increases and cytokine secretion.

Myrtek D, Müller T, Geyer V, Derr N, Ferrari D, Zissel G, Dürk T, Sorichter S, Luttmann W, Kuepper M, Norgauer J, Di Virgilio F, Virchow JC Jr, Idzko M.

J Immunol. 2008 Aug 1;181(3):2181-8.

Supplemental Content

Loading ...
Support Center